Abstract
One may view dry eye conditions as a group of diseases in which the ocular surface is adversely affected. Tear film instability invariably leads to some degree of cellular surface damage over the cornea and conjunctiva. In turn, ocular epitheliopathy may adversely affect tear film stability. The clinical presentation of the disease may not yield a clue as to its etiology. In recent years considerable progress was made both in the diagnosis and the treatment of the disease and promising studies are planned or are underway.
The diagnostic techniques can be divided into four groups. The first is concerned with the clinical presentation. The second is concerned with the bulk properties of the aqueous tears including dynamic characteristics, composition, and colligative properties. The third is tear-film related and includes the film break-up time, evaporation rate, and lipid abnormality. The fourth is concerned with the ocular surface and includes vital staining, impression cytology, and surface microscopy. The most promising attempts are being made in the second group by attempting to elucidate the role of enzyme and enzyme activator activity and inhibitor contents as well as the tear protein profiles and correlating them with the specific disease states.
The treatment modalities belong to three major groups aside from surgical intervention; thesupplementation, preservation, and the stimulation of tears. The modern version of tear supplementation is expected to include the topical use of efficacious aqueous formulations that typically contain film stabilizing polymers, nutrients, and/or — in the future — biochemically active ingredients such as enzyme activators and inhibitors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Holly FJ. Vitamins and polymers in the treatment of ocular surface disease. Contact Lens Spectrum 1990; May: 37–42.
Schirmer O. Studien zur Physiologie und Pathologie der Tränen absonderung und Tränen abführ. Graefe's Arch Opthalmol 1903; 56; 197–291.
Holly FJ, Lamberts DW, Esquivel ED: Kinetics of capillary tear flow in the Schirmer strip. Curr Eye Res 1982; 3: 57–70.
Holly FJ, LauKaitis SJ, Esquivel ED: Kinetics of lacrimal secretion in normal human subjects. Curr Eye Res 1984; 5: 897–910.
Holly FJ, Beebe WE, Esquivel ED: Lacrimation kinetics in humans as determined by a novel technique. In: Holly FJ, Lamberts DW, MacKeen DL, eds. Preocular Tear Film in Health, Disease, and Contact Lens Wear. Lubbock, TX: Dry Eye Institute 1986: 76–88.
Mishima S, Gasset T, Klyce SD Jr, Baum JL: Determination of tear volume and tear flow. Invest Opthalmol 1966; 5: 265–276.
Holly FJ, Lamberts DW: Effect of non-isotonic solutions on tear film osmolality. Inv Opthalmol Vis Sci 1981; 20: 236–245.
Gilbard JP, Farris RL, Santamaria J: Osmolarity of tear micro-volumes in keratoconjunctivitis sicca. Arch Opthalmol 1978; 96: 677–681.
Rolando M, Baldi F, Calabria GA: Tear mucus ferning test in keratoconjunctivitis sicca. In: Holly FJ, Lamberts DW, MacKeen DL eds. Preocular Tear Film in Health, Disease, and Contact Lens Wear. Lubbock, TX: Dry Eye Institute 1986: 203–210.
Orosi P, Berta A, Holly FJ: Cytology of the tear fluid: Quantitative and qualitative evaluation of cells in cyto-centrifuged preparations of normal and pathological tears. [submitted to Curr Eye Res].
Bonavida B, Sapse AT: Human tear lysozyme. II. Quantitative determination with standard Schirmer strip. Am J Ophthalmol 1968; 66: 70–76.
van Bijsterveld OP: Diagnostic tests in the sicca syndrome. Arch Opthalmol 1969; 82: 10–14.
van Bijsterveld OP: Standardization of the lysozyme test for a commercially available medium. Its use in the sicca syndrome. Arch Opthalmol 1974; 91: 432–434.
Boothe DW, Holly FJ, Nichol D, Boothe LA, Lamberts DW: Lysozyme content of tears and saliva from sicca patients and normals. Suppl Invest Opthalmol (ARVO Abstracts) 1983; p 79.
Janssen PT, van Bijsterveld OP: A simple test for lacrimal function: A tear lactoferrin assay by radial immunodiffusion. Graefe's Arch Clin Exp Opthalmol 1983; 220: 171–174.
Punyiczki M, Berta A, Tözsér: Study of neutral proteinases of human tear samples using gels containing copolymerized substrates. Clin Chem Enzym Comms 1988; 1: 115–124.
Berta A, Tözsér J, Holly FJ: Determination of plasminogen activator activities in normal and pathological tears. The significance of tear plasminogen activator in the inflammatory and traumatic lesions of the cornea and conjunctiva. Acta Opthalmol (Kbh) 1990; 68: 92–98.
Holly FJ: Formation and rupture of the tear film in the eye. Exp Eye Res 1973; 15: 515–525.
Norn MS: Dessication of the precorneal film. I. Corneal wetting time. Acta Opthalmol (Kbh) 1969; 47: 865–880.
Lemp MA, Hamill JR: Factors affecting tear film break-up in normal eyes. Arch Opthalmol 1973; 89: 103–105.
Mengher LS, Bron AJ, Tonge SR, Gilbert DJ: Effect of fluorescein instillation on the precorneal tear film stability. Curr Eye Res 1985; 4: 9–12.
Mengher LS, Bron AJ, Tonge SR, Gilbert DJ: Novel noninvasive technique for the clinical assessment of the tear film stability. Curr Eye Res 1985; 4: 9–12.
Hamano H, Honi M, Kawabe H, Umeno M, Mitsugana S: Bio-differential interference microscopic observations on anterior segment of the eye. Second report: Observations of dry spots of tear film. J Jpn Cl Soc 1979; 21: 247–255.
Rolando M, Refojo MF, Kenyon KR: Increased tear vaporation rate in eyes with keratoconjunctivitis sicca. Arch Ophthalmol 1983; 101: 557–558.
Iwata S, Lemp MA, Holly FJ: Evaporation rate of water from the precorneal tear film and cornea in the rabbit. Invest Ophthalmol 1969; 8: 613–619.
Holly FJ: Physical chemistry of the normal and diordered tear film. Trans Ophthalmol Soc UK 1985; 104: 374–380.
McCulley JP, Dougherty JM: Classification of chronic blepharitis. Ophthalmol (Rochester) 1982; 89: 1170–1172.
McDonald JE: Surface phenomena of tear films. Trans Am Ophthalmol Soc 1968; 66: 905–939.
Norn MS, External Eye. Methods of Examination. Copenhagen: Scriptor 1983:153.
Norn MS, External Eye. Methods of Examination. Copenhagen: Scriptor 1983: 212.
Norn MS: Cytology of the conjunctival fluid. Acta Ophthalmol (Kbh) Suppl 1960; 59: 1–152.
Egbert PR, Lauber MA, Maurice DM: A simple conjunctival biopsy. Am J Ophthalmol 1977; 84: 798–801.
Adam AD: The morphology of the human conjunctival mucus. Arch Ophthalmol 1977; 84: 798–801.
Nelson JD: Ocular surface impression cytology using cellulose acetate filter material. Ocular Pemphigoid. Surv Ophthalmol 1982; 27: 67–69.
Götz ML, Jaeger W, Kruse FE: Die Impressionszytologie als nicht invasive Methode der Bindehaut-Biopsie und ihre Ergebnisse. Klin Mbl Augenheilk 1986; 188: 23–28.
Lohman LE, Rao GN, Tripathi RC, Tripathi BJ, Aquavella JV. In vivo specular microscopy of edematous corneal epithelium with light and scanning electron microscopic correlation. Ophthalmology (Rochester) 1982; 89: 621–629.
Lemp MA, Mathers WD: The corneal surface in keratoconjunctivitis sicca. In: Holly FJ, Lamberts DW, MacKeen DL, eds. Preocular Tear Film in Health, Disease, and Contact Lens Wear. Lubbock, TX: Dry Eye Institute 1986: 840–846.
Holly FJ. Pharmacology of Ocular Lubricants. Chapter 57 in Optometric Pharmacology and Therapeutics. Ed. by B. Onofrey, Lipincott, Philadelphia, 1992.
Holly FJ. Modern tear substitutes in the primary care of dry eyes. Optometry Today, Jan/Feb., 1992, p. 25.
Holly FJ, Esquivel ED. Colloid osmotic pressure of artificial tears. J Ocul Pharmacol 1985; 1: 327–336.
Holly FJ. Biophysical aspects of epithelial adhesion to stroma and its clinical application. Inv Ophthalmol 1978; 17: 552–557.
Adler C, Maurice DM, Patterson ME. The effect of viscosity on the pentration of fluorescein into the human eye. Exp Eye Res 1971; 11: 34–39.
Flynn T: A multi-pronged approach in alleviating dry eye problems. In: Holly FJ, Lamberts DW, MacKeen DL, eds. Preocular tear film in health, disease, and contact lens wear. Lubbock, TX: Dry Eye Institute 1986: 212–220.
Doane MG. Mechanical devices. In: Holly FJ, Lemp MA eds. The preocular tear film and dry eye syndrome. Intern Ophthalmol Clin 1973; 13: 239–244.
Gilbard JP, Kenyon KR. Tear diluents in the treatment of keratoconjunctivitis sicca. Arch Ophthalmol 1985; 92: 646–650.
Gilbard JP, Rossi SR, Heyda KG. Ophthalmic solutions, the ocular surface, and a unique therapeutic artificial tear formulation [see also ref. 47] Am J Ophthalmol 1989; 107: 348–355.
Comment on ref. 46 in the Am J Ophthalmol 1989; 108: 94–95.
Williams VR, Williams HB. Basic physical chemistry for the life sciences. 2nd ed. San Francisco: Freeman and Co. 1973: 121–123.
Holly FJ. Artificial tear formulations. Contact Lens Forum, 1988; June: 30–38.
Tseng S C-G. Cytological evidence of topical retinoic acid on dry eye disorders. In: Holly FJ, Lamberts DW, MacKeen DL, eds. Preocular tear film in health, disease, and contact lens wear. Lubbock, TX: Dry Eye Institute 1986: 253–270.
Foulks GN. A clinical comparison of topical therapy for dry eye (submitted, Dakryon Pharmaceuticals).
Lamberts DW. Punctal occlusion in the dry eye. In: Holly FJ, Lamberts DW, MacKeen DL, eds. Preocular tear film in health, disease, and contact lens wear. Lubbock, TX: Dry Eye Institute 1986: 247–252.
Norn MS. The effect of drugs on tear secretion. In: Holly FJ, Lamberts DW, MacKeen DL, eds. Preocular tear film in health, disease, and contact lens wear. Lubbock, TX: Dry Eye Institute 1986: 221–229.
Lacrisert®, Med Lett Drugs Ther 1981; 23(24): 104.
Prause JU. Treatment of keratoconjunctivitis sicca with Lacrisert. Scand J Rheumatol Suppl 1986; 61: 261–263.
Marquardt R. Die Bedhändlung des Trockenen Auges mit einem tropfähigen Gel [Treatment of dry eye with a new gel in eye drop form]. Klin Monatsbl Augenheilk 1986; 189: 51–54.
Holly FJ, Holly TF, Advances in ocular tribology (submitted for publication)
Lemp MA, Dohlman CH, Holly FJ. Corneal desiccation despite normal tear volume. Ann Ophthalmol 1970; 2: 258–261.
Holly FJ. Diagnosis and treatment of dry eye syndrome; An evaluation of two surveys. Contact Lens Spectrum, 1989; July: 37–44.
Manthorpe R, Petersen S, Prause JU: Mucosolvan® in the treatment of patients with primary Sjögren's syndrome. Results from a double-blind cross-over investigation. Acta Ophthalmol (Kbh) 1984; 62: 537–541.
Götz ML, Jaeger W, Kaercher T. Eledoisin: A new approach to the treatment of dry eye states. In: Holly FJ, Lamberts DW, MacKeen DL, eds. Preocular tear film in health, disease, and contact lens wear. Lubbock, TX: Dry Eye Institute 1986: 230–238.
Kaswan RK, Salisbury MA, Ward DA, Martin CL, Ramsey JM, Kemp DT. Cyclosporin eye drops: Preliminary report on a new therapy for keratoconjunctivitis sicca. (to be published in J Am Vet Med Assoc).